See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.
Digital RESI event
Oxford, UK – We’ll be joining startups, technology partners and global investors at digital ‘Redefining Early Stage Investments’ (RESI)…
27/07/20
PrecisionLife CEO speaks to the 20/15 Visioneers Rock Stars podcast
Oxford, UK – PrecisionLife CEO Dr Steve Gardner was a guest on the thoroughly entertaining 20/15 Visioneers podcast last…
17/07/20
PrecisionLife present at One Nucleus’ ON Helix event
Oxford, UK – Find out a little more about PrecisionLife at the digital ON Helix 20 event next week…
14/07/20
Combinatorial analysis of phenotypic and clinical risk factors associated with hospitalized COVID-19 patients
A study using de-identified clinical claims and labs data for US COVID-19 patients. We replicated previous findings around the…
25/02/21
The COVID-19 PHARMACOME: Rational Selection of Drug Repurposing Candidates from Multimodal Knowledge Harmonization
The SARS-CoV-2 pandemic has challenged researchers at a global scale. The scientific community’s massive response has resulted in a…
26/05/21
AI Enabled Precision Medicine: Patient Stratification, Drug Repurposing and Combination Therapies
Access to huge patient populations with well-characterized datasets, coupled with novel analytical methods, enables the stratification of complex diseases…
26/06/20
PrecisionLife featured in Financial Times
Oxford, UK – PrecisionLife has been featured in a Financial Times article following our discovery of 68 genes associated…
25/06/2068 risk-associated genes identified from analysis of hospitalized COVID-19 patients
Oxford, UK – PrecisionLife’s unique AI platform has found 68 genes associated with risk of developing severe COVID-19 after…
24/06/20
BIA Life Science Leadership Summit event
Oxford, UK – PrecisionLife CEO Steve Gardner and CMO Veronique Bouchet will be leading a workshop on AI/Data Led…
22/06/20
‘Finding Hidden Treasures’ session at BIO International Convention
Oxford, UK – PrecisionLife CEO Dr Steve Gardner will speak on the panel of today’s ‘Finding Hidden Treasures’ session…
10/06/20‘Digital Biomarkers’ session at BIO International Convention
Oxford, UK – PrecisionLife CEO Dr Steve Gardner will speak on the panel of today’s ‘Digital Biomarkers – a…
8/06/20Women in Biotech event
Oxford, UK – PrecisionLife CMO Dr Veronique Bouchet will be chairing a session at the BIA’s upcoming Women in…
4/06/20
59 potential drug re-purposing candidates identified in fight against COVID-19
Oxford, UK – Using PrecisionLife’s proprietary AI enabled precision medicine platform we have identified 59 re-purposing drug candidates that…
5/05/20Systematic drug repurposing to enable precision medicine: A case study in breast cancer
Precision medicine and drug repurposing provide an opportunity to ameliorate the challenges of declining pharmaceutical R&D productivity, rising costs…
13/04/20PrecisionLife offers support to COVID-19 coronavirus research community
Oxford, UK – PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research…
6/04/20
RowAnalytics becomes PrecisionLife in exciting rebrand
Oxford, UK – Building on its guiding principles of insight and innovation, AI-enabled precision medicine company RowAnalytics Ltd has…
24/11/19A New Lens, European Biopharmaceutical Review
Access to huge patient datasets and improvements in analytical methods is enabling the teasing apart of complex diseases into…
1/07/19Delivering personalized dietary advice for health management and disease prevention
Background and Objectives: Diet plays a huge role in health, both by increasing metabolic disease risks and acutely through…
18/10/18